| Correlates of protection against SARS-CoV-2 in rhesus macaques K McMahan, J Yu, NB Mercado, C Loos, LH Tostanoski, A Chandrashekar, ... Nature 590 (7847), 630-634, 2021 | 1170 | 2021 |
| DNA vaccine protection against SARS-CoV-2 in rhesus macaques J Yu, LH Tostanoski, L Peter, NB Mercado, K McMahan, SH Mahrokhian, ... Science 369 (6505), 806-811, 2020 | 1170 | 2020 |
| Potently neutralizing and protective human antibodies against SARS-CoV-2 SJ Zost, P Gilchuk, JB Case, E Binshtein, RE Chen, JP Nkolola, A Schäfer, ... Nature 584 (7821), 443-449, 2020 | 1153 | 2020 |
| Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques NB Mercado, R Zahn, F Wegmann, C Loos, A Chandrashekar, J Yu, J Liu, ... Nature 586 (7830), 583-588, 2020 | 999 | 2020 |
| SARS-CoV-2 infection protects against rechallenge in rhesus macaques A Chandrashekar, J Liu, AJ Martinot, K McMahan, NB Mercado, L Peter, ... Science 369 (6505), 812-817, 2020 | 964 | 2020 |
| Vaccine protection against Zika virus from Brazil RA Larocca, P Abbink, JPS Peron, PM de A. Zanotto, MJ Iampietro, ... Nature 536 (7617), 474-478, 2016 | 618 | 2016 |
| Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys P Abbink, RA Larocca, RA De La Barrera, CA Bricault, ET Moseley, ... Science 353 (6304), 1129-1132, 2016 | 580 | 2016 |
| Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys EN Borducchi, J Liu, JP Nkolola, AM Cadena, WH Yu, S Fischinger, ... Nature 563 (7731), 360-364, 2018 | 349 | 2018 |
| Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters LH Tostanoski, F Wegmann, AJ Martinot, C Loos, K McMahan, ... Nature medicine 26 (11), 1694-1700, 2020 | 311 | 2020 |
| Durability and correlates of vaccine protection against Zika virus in rhesus monkeys P Abbink, RA Larocca, K Visitsunthorn, M Boyd, RA De La Barrera, ... Science translational medicine 9 (420), eaao4163, 2017 | 138 | 2017 |
| Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail B Julg, PT Liu, K Wagh, WM Fischer, P Abbink, NB Mercado, JB Whitney, ... Science translational medicine 9 (408), eaao4235, 2017 | 136 | 2017 |
| Comparison of subgenomic and total RNA in SARS-CoV-2-challenged rhesus macaques G Dagotto, NB Mercado, DR Martinez, YJ Hou, JP Nkolola, RH Carnahan, ... Journal of virology 95 (8), 10.1128/jvi. 02370-20, 2021 | 123 | 2021 |
| Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine MS Gebre, S Rauch, N Roth, J Yu, A Chandrashekar, NB Mercado, X He, ... Nature 601 (7893), 410-414, 2022 | 122 | 2022 |
| Low-dose Ad26. COV2. S protection against SARS-CoV-2 challenge in rhesus macaques X He, A Chandrashekar, R Zahn, F Wegmann, J Yu, NB Mercado, ... Cell 184 (13), 3467-3473. e11, 2021 | 58 | 2021 |
| Protective efficacy of Ad26. COV2. S against SARS-CoV-2 B. 1.351 in macaques J Yu, LH Tostanoski, NB Mercado, K McMahan, J Liu, C Jacob-Dolan, ... Nature 596 (7872), 423-427, 2021 | 48 | 2021 |
| Feasibility and safety of ultrasound-guided minimally invasive autopsy in COVID-19 patients OR Brook, KG Piper, NB Mercado, MS Gebre, DH Barouch, ... Abdominal Radiology 46, 1263-1271, 2021 | 44 | 2021 |
| Immunity elicited by natural infection or Ad26. COV2. S vaccination protects hamsters against SARS-CoV-2 variants of concern LH Tostanoski, J Yu, NB Mercado, K McMahan, C Jacob-Dolan, ... Science translational medicine 13 (618), eabj3789, 2021 | 37 | 2021 |
| Rapid cloning of novel rhesus adenoviral vaccine vectors P Abbink, M Kirilova, M Boyd, N Mercado, Z Li, R Nityanandam, ... Journal of virology 92 (6), 10.1128/jvi. 01924-17, 2018 | 35 | 2018 |
| SARS-CoV-2 binding and neutralizing antibody levels after Ad26. COV2. S vaccination predict durable protection in rhesus macaques R Roozendaal, L Solforosi, DJ Stieh, J Serroyen, R Straetemans, A Dari, ... Nature Communications 12 (1), 5877, 2021 | 32 | 2021 |
| Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques AM Cadena, JD Ventura, P Abbink, EN Borducchi, H Tuyishime, ... Nature communications 12 (1), 1474, 2021 | 32 | 2021 |
